MODURETIC 5-50 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Moduretic 5-50, and when can generic versions of Moduretic 5-50 launch?
Moduretic 5-50 is a drug marketed by Merck and is included in one NDA.
The generic ingredient in MODURETIC 5-50 is amiloride hydrochloride; hydrochlorothiazide. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amiloride hydrochloride; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Moduretic 5-50
A generic version of MODURETIC 5-50 was approved as amiloride hydrochloride; hydrochlorothiazide by BARR on May 10th, 1988.
Summary for MODURETIC 5-50
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 2 |
Patent Applications: | 114 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MODURETIC 5-50 at DailyMed |
Recent Clinical Trials for MODURETIC 5-50
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GlaxoSmithKline | Phase 1 |
Centre Hospitalier Universitaire de Saint Etienne | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for MODURETIC 5-50
US Patents and Regulatory Information for MODURETIC 5-50
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | MODURETIC 5-50 | amiloride hydrochloride; hydrochlorothiazide | TABLET;ORAL | 018201-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MODURETIC 5-50
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | MODURETIC 5-50 | amiloride hydrochloride; hydrochlorothiazide | TABLET;ORAL | 018201-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MODURETIC 5-50
See the table below for patents covering MODURETIC 5-50 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Sweden | 307948 | ⤷ Try a Trial | |
Belgium | 653479 | ⤷ Try a Trial | |
Cyprus | 440 | Pyrazinoylguanidine derivatives | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |